These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Jan. 16 through Jan. 22, 2025. Source: VerityData

Original Filings

Accolade $(ACCD)$ Magnetar Financial disclosed a new position in the healthcare technology company of 5,135,671 shares. Magnetar Financial purchased those shares from Jan. 8 through Jan. 17, 2025, at per-share prices ranging from $6.83 to $6.89. Magnetar Financial is probably making an arbitrage play.

On Jan. 8, Accolade announced that it has entered into a definitive agreement to be acquired by Transcarent for $7.03 per share in cash, valuing the deal at $621 million. Accolade's board of directors unanimously approved the merger agreement and has resolved to recommend that the company's stockholders approve the merger at its next annual meeting.

Following the purchases, Magnetar Financial owns an initial 6.3% stake of Accolade's outstanding stock.

Increases in Holdings

Zymeworks$(ZYME)$ EcoR1 Capital raised its stake in the oncology-focused biopharmaceutical company to 15,411,078 shares. EcoR1 Capital purchased 718,797 Zymeworks shares from Dec. 24, 2024, through Jan. 10, 2025, at per share prices ranging from $13.13 to $14.78.

Following the latest purchases, EcoR1 continues to own 22.4% of Zymeworks' outstanding stock. Shares of Zymeworks have gained more than a third in value since the beginning of 2024.

Auna$(AUNA)$ Grupo Ángeles Servicios de Salud increased its stake in the healthcare provider to 7,214,062 shares. Grupo Ángeles did so through the purchase of 554,062 Auna shares from Dec. 2, 2024, through Jan. 14, 2025, at per share prices ranging from $6.51 to $7.70.

Following the latest purchases, Grupo Ángeles owns 24.1% of Auna's outstanding stock. Shares of Auna have lost nearly a fifth in value since the company began trading in March 2024.

Decreases in Holdings

Dell Technologies$(DELL)$ Silver Lake reduced its stake in the computer maker to 62,513,399 shares. Silver Lake and its affiliates did so through the sale of 2,958,810 Dell Technologies shares from Dec. 5, 2024, through Jan. 8, 2025, at per share prices ranging from $118.01 to $124.

Following the sales, Silver Lake owns 14.8% of Dell Technologies' outstanding stock. Shares of Dell Technologies have surged to gain roughly 55.7% since the beginning of 2024.

GATX $(GATX)$ Gamco Investors reduced its stake in the car-leasing company to 2,329,615 shares. Gamco Investors sold a net of 34,190 GATX shares from Nov. 15, 2024, through Jan. 15, 2025, at per share prices ranging from $150.05 to $167.06.

Following the latest sales, Gamco Investors continues to own 6.6% of GATX's outstanding stock. Shares of GATX have gained more than a quarter in value since the beginning of 2024.

Email: editors@barrons.com

To subscribe to Barron's, visit http://www.barrons.com/subscribe

(END) Dow Jones Newswires

January 24, 2025 21:30 ET (02:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.